Welcome, Vagabond. - Register?
Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Russian vaccine "Bluff" Pfizer
[Image: BB1aQMZ9.img?h=426&w=640&m=6&q=60&o=f&l=f.jpg]

Which Pfizer's success It puts the company on the path of getting approval for an emergency release from the US Food and Drug Administration later this month.
The announcement came less than a week after the presidential election, which is seen as a referendum on President Donald Trump's handling of the crisis, and is a rare and important piece of encouraging news. In recent times, in the fight against a catastrophe that has killed more than one million and two hundred thousand people worldwide, including nearly two hundred and 50,000 in the United States. With more than 10 million confirmed infections on Monday.
Dr. Anthony Fauci, the government's highest ranked infectious disease specialist Said the findings suggest that 90 percent of the effectiveness was "extraordinary" and "not many people expected it to reach that level".
Pharmaceutical companies and countries are in a global race to develop vaccines against the virus. But Monday's announcement does not mean the vaccine is close to being available.
Information disclosed is a transitional analysis. From the Independent Audit Committee It examined the infection data of 94 volunteers from nearly 44,000 people in the US and five other countries, with some of the participants being vaccinated. While others received fake vaccines.
Pfizer did not provide further details on those infections. And warned that the early defense rate May change once the study is over But even it was early disclosure This level of efficiency is very unusual.
Authorities have stressed that no vaccine will be released before the end of the year.

[Image: BB1aQYko.img?h=427&w=640&m=6&q=60&o=f&l=f.jpg]

As a representative of the Russian Ministry of Health Was revealed on the same day that Russia's Sputnikov vaccine is more than 90 percent effective against COVID-19. It cited information gathered from people who were vaccinated themselves. Rather than the information that comes from the research of scientists.
The comments came after Pfizer's announcement.
Aksana Drapkina, director of the research institute under the Ministry of Health of Russia. Told in a statement that “We are responsible for monitoring the effectiveness of the Sputnik V vaccine among vaccinated individuals. This is part of a “mass vaccination” program among citizens. Its efficiency is more than 90 percent as well. Another effective vaccine coming out It is good news for everyone. "
On the same day Alexander Ginsberg, director of the Kamalea Institute in Moscow, who developed Russian vaccine candidates. Congratulated Pfizer's news and said, "In the near future We are expected to publish transitional test results. สล็อตออนไลน์ After the registration of the Sputnik V vaccine, which was called the Phase III trial, and I am confident that the effective level of the vaccine was Will be high as well "
Russia is preparing to publish the preliminary results of a number of ongoing human trials. Known as Phase III this month, they are testing the vaccine on 40,000 people in Moscow.

Forum Jump:

Users browsing this thread: 1 Guest(s)